Basimglurant

( DrugBank: Basimglurant / KEGG DRUG: Basimglurant )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
158	結節性硬化症	1

158. 結節性硬化症

臨床試験数 : 112 / 薬物数 : 71 - (DrugBank : 19) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 118

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05059327 (ClinicalTrials.gov)	March 3, 2021	20/8/2021	Basimglurant in Children, Adolescents, and Young Adults With TSC	A Phase 2B, Multicenter, 30-week, Prospective, Cross-over, Double-blind, Randomized, Placebo-control ...	Tuberous Sclerosis Complex	Drug: Basimglurant with crossover to Placebo;Drug: Placebo with crossover to Basimglurant	Noema Pharma AG	NULL	Recruiting	5 Years	30 Years	All	54	Phase 2	United States;Australia;India;Israel;Italy;Poland;Spain;Turkey;United Kingdom

First Previous1Next Last